20 results on '"Khalili, Nastaran"'
Search Results
2. Training and Comparison of nnU-Net and DeepMedic Methods for Autosegmentation of Pediatric Brain Tumors.
- Author
-
Vossough, Arastoo, Khalili, Nastaran, Familiar, Ariana M., Gandhi, Deep, Viswanathan, Karthik, Wenxin Tu, Haldar, Debanjan, Bagheri, Sina, Anderson, Hannah, Haldar, Shuvanjan, Storm, Phillip B., Resnick, Adam, Ware, Jeffrey B., Nabavizadeh, Ali, and Kazerooni, Anahita Fathi
- Published
- 2024
- Full Text
- View/download PDF
3. Statistical plots in oncologic imaging, a primer for neuroradiologists.
- Author
-
Bagheri, Sina, Taghvaei, Mohammad, Familiar, Ariana, Haldar, Debanjan, Zandifar, Alireza, Khalili, Nastaran, Vossough, Arastoo, and Nabavizadeh, Ali
- Abstract
The simplest approach to convey the results of scientific analysis, which can include complex comparisons, is typically through the use of visual items, including figures and plots. These statistical plots play a critical role in scientific studies, making data more accessible, engaging, and informative. A growing number of visual representations have been utilized recently to graphically display the results of oncologic imaging, including radiomic and radiogenomic studies. Here, we review the applications, distinct properties, benefits, and drawbacks of various statistical plots. Furthermore, we provide neuroradiologists with a comprehensive understanding of how to use these plots to effectively communicate analytical results based on imaging data. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging.
- Author
-
Khalili, Nastaran, Shooli, Hossein, Hosseini, Nastaran, Fathi Kazerooni, Anahita, Familiar, Ariana, Bagheri, Sina, Anderson, Hannah, Bagley, Stephen J., and Nabavizadeh, Ali
- Subjects
BRAIN tumor diagnosis ,PROFESSIONAL practice ,NEUROLOGY ,BLOOD-brain barrier ,DNA ,CENTRAL nervous system tumors ,EARLY detection of cancer ,MAGNETIC resonance imaging ,POSITRON emission tomography computed tomography ,BRAIN tumors ,BODY fluid examination ,TUMOR markers ,CANCER patient medical care - Abstract
Simple Summary: Clinical management in neuro-oncology has shifted to an integrated method that combines molecular profiles with histopathological and imaging data. Liquid biopsy is a non-invasive method that captures the molecular diversity of the whole tumor by detecting specific tumor biomarkers that circulate in body fluids like the cerebrospinal fluid. However, the limited presence and short half-life of tumor-derived biomarkers, especially in central nervous system (CNS) tumors, have restricted the use of liquid biopsy in clinical settings. Here, we review the diverse clinical applications of liquid biopsy in CNS tumors and discuss the added value of imaging in enhancing the release and detection of circulating tumor biomarkers. Clinical management in neuro-oncology has changed to an integrative approach that incorporates molecular profiles alongside histopathology and imaging findings. While the World Health Organization (WHO) guideline recommends the genotyping of informative alterations as a routine clinical practice for central nervous system (CNS) tumors, the acquisition of tumor tissue in the CNS is invasive and not always possible. Liquid biopsy is a non-invasive approach that provides the opportunity to capture the complex molecular heterogeneity of the whole tumor through the detection of circulating tumor biomarkers in body fluids, such as blood or cerebrospinal fluid (CSF). Despite all of the advantages, the low abundance of tumor-derived biomarkers, particularly in CNS tumors, as well as their short half-life has limited the application of liquid biopsy in clinical practice. Thus, it is crucial to identify the factors associated with the presence of these biomarkers and explore possible strategies that can increase the shedding of these tumoral components into biological fluids. In this review, we first describe the clinical applications of liquid biopsy in CNS tumors, including its roles in the early detection of recurrence and monitoring of treatment response. We then discuss the utilization of imaging in identifying the factors that affect the detection of circulating biomarkers as well as how image-guided interventions such as focused ultrasound can help enhance the presence of tumor biomarkers through blood–brain barrier (BBB) disruption. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Radiomics for characterization of the glioma immune microenvironment.
- Author
-
Khalili, Nastaran, Kazerooni, Anahita Fathi, Familiar, Ariana, Haldar, Debanjan, Kraya, Adam, Foster, Jessica, Koptyra, Mateusz, Storm, Phillip B., Resnick, Adam C., and Nabavizadeh, Ali
- Subjects
RADIOMICS ,GLIOMAS ,BRAIN tumors ,GENOMICS ,TUMOR microenvironment ,TISSUE analysis - Abstract
Increasing evidence suggests that besides mutational and molecular alterations, the immune component of the tumor microenvironment also substantially impacts tumor behavior and complicates treatment response, particularly to immunotherapies. Although the standard method for characterizing tumor immune profile is through performing integrated genomic analysis on tissue biopsies, the dynamic change in the immune composition of the tumor microenvironment makes this approach not feasible, especially for brain tumors. Radiomics is a rapidly growing field that uses advanced imaging techniques and computational algorithms to extract numerous quantitative features from medical images. Recent advances in machine learning methods are facilitating biological validation of radiomic signatures and allowing them to "mine" for a variety of significant correlates, including genetic, immunologic, and histologic data. Radiomics has the potential to be used as a non-invasive approach to predict the presence and density of immune cells within the microenvironment, as well as to assess the expression of immune-related genes and pathways. This information can be essential for patient stratification, informing treatment decisions and predicting patients' response to immunotherapies. This is particularly important for tumors with difficult surgical access such as gliomas. In this review, we provide an overview of the glioma microenvironment, describe novel approaches for clustering patients based on their tumor immune profile, and discuss the latest progress on utilization of radiomics for immune profiling of glioma based on current literature. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study.
- Author
-
Kazerooni, Anahita Fathi, Arif, Sherjeel, Madhogarhia, Rachel, Khalili, Nastaran, Haldar, Debanjan, Bagheri, Sina, Familiar, Ariana M, Anderson, Hannah, Haldar, Shuvanjan, Tu, Wenxin, Kim, Meen Chul, Viswanathan, Karthik, Muller, Sabine, Prados, Michael, Kline, Cassie, Vidal, Lorenna, Aboian, Mariam, Storm, Phillip B, Resnick, Adam C, and Ware, Jeffrey B
- Published
- 2023
- Full Text
- View/download PDF
7. The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer.
- Author
-
Pirzadeh, Marzieh, Khalili, Nastaran, and Rezaei, Nima
- Subjects
ARYL hydrocarbon receptors ,HELICOBACTER pylori ,STOMACH cancer ,TRYPTOPHAN ,CARCINOGENESIS ,HELICOBACTER pylori infections - Abstract
Several risk factors are known to be involved in the initiation and development of gastric cancer. Among them, H. pylori is one of the most prominent with multiple virulence factors contributing to its pathogenicity. In this study, we have discussed an interesting immunological cycle exploring the interplay between H. pylori, aryl hydrocarbon receptor (AHR), tryptophan, arginine, and the metabolites of these two amino acids in the development of gastric cancer. AHR is a ligand-activated transcription factor which acts as a regulator for a diverse set of genes and has various types of exogenous and endogenous ligands. The tryptophan metabolite, kynurenine, is one of these ligands that can interact with AHR, leading to immune suppression and subsequently, susceptibility to gastric cancer. On the other hand, H. pylori downregulates the expression of AHR and AHR repressor (AHRR), leading to increased inflammatory cytokine production. A metabolite of the kynurenine pathway, xanthurenic acid, is a potent inhibitor of a terminal enzyme in the synthetic pathway of tetrahydrobiopterin (BH4). BH4, itself, is a cofactor in the process of nitric oxide (NO) production from arginine that has been shown to have immune-enhancing properties. Arginine has also been evidenced to have anti-tumoral function through inducing apoptosis in gastric cell lines; however, controversy exists regarding the anti-tumor role of arginine and BH4, since they are also associated with increased NO production, subsequently promoting tumor angiogenesis. Hence, although several synergistic connections result in immunity improvement, these correlations can also act as a double-edged sword, promoting tumor development. This emphasizes on the need for further investigations to better understand this complex interplay. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Primary Pleuropulmonary Synovial Sarcoma: Report of Two Cases and a Comprehensive Review of the Literature.
- Author
-
Khalili, Neda, Askari, Elham, Khalili, Nastaran, Daneshvar-Kakhki, Aboulghasem, Sadr, Makan, Haseli, Sara, and Pourabdollah Toutkaboni, Mihan
- Subjects
MOLECULAR diagnosis ,IMMUNOHISTOCHEMISTRY ,LUNG tumors ,FLUORESCENCE in situ hybridization ,CYTOGENETICS ,SARCOMA - Abstract
Primary sarcomas of the lung represent less than 0.5% of all primary lung tumors and comprise a heterogeneous group of malignancies including synovial sarcoma (SS). Primary pleuropulmonary SS has non-specific presentations, such as chest pain, shortness of breath and cough, and its associated imaging features resemble those of other intrathoracic malignancies. The diagnosis of these tumors needs to be confirmed by cytogenetic and molecular studies. Here, we describe two rare cases of primary pleuropulmonary SS who were admitted to our hospital. We also provide a concise review of clinical, radiological, and histopathological characteristics of pleuropulmonary SS after exploring 168 studies (415 corresponding patients) that were identified through a literature search. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Organizing pneumonia-like pattern in COVID-19.
- Author
-
Raoufi, Masoomeh, Kahkooei, Shahram, Haseli, Sara, Robatjazi, Farzaneh, Bahri, Jamileh, and Khalili, Nastaran
- Published
- 2021
- Full Text
- View/download PDF
10. Early post‐operative acute kidney injury after cardiac transplantation: Incidence and predictive factors.
- Author
-
Jahangirifard, Alireza, Ahmadi, Zargham Hossein, Khalili, Nastaran, Naghashzadeh, Farah, Afshar, Ali, Amiri, Arvin, and Dalili, Nooshin
- Subjects
ACUTE kidney failure ,SURGICAL complications ,HEART transplantation ,HEART assist devices ,KIDNEY transplantation ,HEART injuries ,OPERATIVE surgery - Abstract
Background: Heart transplantation, as a therapeutic option for patients with advanced heart failure, possesses a high rate of morbidity and mortality. One of the complications associated with this procedure is the development of postoperative acute kidney injury (AKI) Material and methods: We aimed to evaluate the incidence of early postoperative AKI and the need for continuous renal replacement therapy (RRT) after heart transplantation. Data of 126 patients who underwent heart transplantation from January 2015 to November 2019 were collected. Statistical analysis was performed to identify the predictors of postoperative AKI. Results: Out of 126 patients, 74 (58.7 %) developed AKI and 13 (10%) required RRT after transplant. Independent predictors of AKI are shown to be factors associated with surgical procedures such as graft ischemic time as were previous cardiac operation, administered Voluven (starch) dose > 400 ml, and transfusion of more than four blood units. Conclusion: Our findings suggest that modifiable factors exist that can affect the risk of developing AKI following heart transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.
- Author
-
Ghaffari, Sasan, Khalili, Nastaran, and Rezaei, Nima
- Subjects
CANCER treatment ,IMMUNOTHERAPY ,CRISPRS ,THERAPEUTICS ,CHIMERIC antigen receptors - Abstract
Cancer immunotherapy has gained attention as the supreme therapeutic modality for the treatment of various malignancies. Adoptive T-cell therapy (ACT) is one of the most distinctive modalities of this therapeutic approach, which seeks to harness the potential of combating cancer cells by using autologous or allogenic tumor-specific T-cells. However, a plethora of circumstances must be optimized to produce functional, durable, and efficient T-cells. Recently, the potential of ACT has been further realized by the introduction of novel gene-editing platforms such as the CRISPR/Cas9 system; this technique has been utilized to create T-cells furnished with recombinant T-cell receptor (TCR) or chimeric antigen receptor (CAR) that have precise tumor antigen recognition, minimal side effects and treatment-related toxicities, robust proliferation and cytotoxicity, and nominal exhaustion. Here, we aim to review and categorize the recent breakthroughs of genetically modified TCR/CAR T-cells through CRISPR/Cas9 technology and address the pearls and pitfalls of each method. In addition, we investigate the latest ongoing clinical trials that are applying CRISPR-associated TCR/CAR T-cells for the treatment of cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Rosai‐Dorfman disease: A case report of asymptomatic isolated renal involvement.
- Author
-
Abrishami, Alireza, Ziaeefar, Pardis, Ebrahimi, Sara, Khalili, Nastaran, Nouralizadeh, Akbar, and Farjad, Reza
- Subjects
NON-langerhans-cell histiocytosis ,DIAGNOSIS ,TIME ,CREATININE - Abstract
A possible diagnosis of RDD should be kept in mind when encountering a patient with raised plasma creatinine levels and renal mass. Timely diagnosis and management of RDD will help prevent future kidney loss. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Living or deceased-donor kidney transplant: the role of psycho-socioeconomic factors and outcomes associated with each type of transplant.
- Author
-
Basiri, Abbas, Taheri, Maryam, Khoshdel, Alireza, Golshan, Shabnam, Mohseni-rad, Hamed, Borumandnia, Nasrin, Simforoosh, Nasser, Nafar, Mohsen, Aliasgari, Majid, Nourbala, Mohammad Hossein, Pourmand, Gholamreza, Farhangi, Soudabeh, and Khalili, Nastaran
- Subjects
ANALYSIS of variance ,ANXIETY ,COMPARATIVE studies ,CONFIDENCE intervals ,CREATININE ,HEALTH services accessibility ,HEALTH status indicators ,HEMODIALYSIS ,LENGTH of stay in hospitals ,INCOME ,INTENSIVE care units ,KIDNEY transplantation ,LONGITUDINAL method ,MEDICAL referrals ,ORGAN donors ,POSTOPERATIVE period ,PROBABILITY theory ,QUESTIONNAIRES ,STATISTICS ,TRANSPLANTATION of organs, tissues, etc. ,MULTIPLE regression analysis ,PSYCHOSOCIAL factors ,SOCIOECONOMIC factors ,EDUCATIONAL attainment ,TREATMENT effectiveness ,REPEATED measures design ,TREATMENT duration ,ODDS ratio - Abstract
Background: Kidney transplant improves patients' survival and quality of life. Worldwide, concern about the equality of access to the renal transplant wait-list is increasing. In Iran, patients have the choice to be placed on either the living or deceased-donor transplant wait-list. Methods: This was a prospective study performed on 416 kidney transplant recipients (n = 217 (52.2%) from living donors and n = 199 (47.8%) from deceased donors). Subjects were recruited from four referral kidney transplant centers across Tehran, Iran, during 2016–2017. The primary outcome was to identify the psycho-socioeconomic factors influencing the selection of type of donor (living versus deceased). Secondary objective was to compare the outcomes associated with each type of transplant. The impact of psycho-socioeconomic variables on selecting type of donor was evaluated by using multiple logistic regression and the effect of surgical and non-surgical variables on the early post-transplant creatinine trend was assessed by univariate repeated measure ANOVA. Results: Based on standardized coefficients, the main predictors for selecting living donor were academic educational level (adjusted OR = 3.25, 95% CI: 1.176–9.005, p = 0.023), psychological status based on general health questionnaire (GHQ) (adjusted OR = 2.46, 95% CI: 1.105–5.489, p = 0.028), and lower monthly income (adjusted OR = 2.20, 95% CI: 1.242–3.916, p = 0.007). The waiting time was substantially shorter in patients who received kidneys from living donors (p < 0.001). The early post-transplant creatinine trend was more desirable in recipients of living donors (β = 0.80, 95% CI: 0.16–1.44, p-value = 0.014), patients with an ICU stay of fewer than five days (β = − 0.583, 95% CI: − 0.643- -0.522, p-value = < 0.001), and those with less dialysis duration time (β = 0.016, 95% CI: 0.004–0.028, p-value = 0.012). Post-operative surgical outcomes were not different across the two groups of recipients (p = 0.08), however, medical complications occurred considerably less in the living-donor group (p = 0.04). Conclusion: Kidney transplant from living donors was associated with shorter transplant wait-list period and better early outcome, however, inequality of access to living donors was observed. Patients with higher socioeconomic status and higher level of education and those suffering from anxiety and sleep disorders were significantly more likely to select living donors. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial.
- Author
-
Aghili, Mahdi, Khalili, Nastaran, Khalili, Neda, Babaei, Mohammad, Farhan, Farshid, Haddad, Peiman, Salarvand, Samaneh, Keshvari, Amir, Fazeli, Mohammad Sadegh, Mohammadi, Negin, and Ghalehtaki, Reza
- Subjects
CHEMORADIOTHERAPY ,RECTAL cancer ,RANDOMIZED controlled trials ,CANCER patients ,COLON cancer ,SURGICAL complications - Abstract
Purpose: Colorectal cancer is becoming an increasing concern in the middle-aged population of Iran. This study aimed to compare the preliminary results of short-course and long-course neoadjuvant chemoradiotherapy treatment for rectal cancer patients. Materials and Methods: In this clinical trial we recruited patients with rectal adenocarcinoma located from 5 cm to 15 cm above the anal verge. Patients in group I (short-course) received three-dimensional conformational radiotherapy with a dose of 25 Gy/5 fractions in 1 week plus concurrent XELOX regimen (capecitabine 625 mg/m² from day 1-5 twice daily and oxaliplatin 50 mg/m² on day 1 once daily). Patients in group II (long-course) received a total dose of 50-50.4 Gy/25-28 fractions for 5 to 5.5 weeks plus capecitabine 825 mg/m² twice daily. Both groups underwent consolidation chemotherapy followed by delayed surgery at least 8 weeks after radiotherapy completion. The pathological response was assessed with tumor regression grade. Results: In this preliminary report on complications and pathological response, 66 patients were randomized into two study groups. Mean duration of radiotherapy in the group II (long-course) was 5 ± 1 days (range, 5 to 8 days) and 38 ± 6 days (range, 30 to 58 days). The median follow-up was 18 months. Pathological complete response was achieved in 32.3% and 23.1% of patients in the shortcourse and long-course groups, respectively (p = 0.558). Overall, acute grade 3 or higher treatment- related toxicities occurred in 24.2% and 22.2% of patients in group I and II, respectively (p = 0.551). No acute grade 4 or 5 adverse events were observed in either group except one grade 4 hematologic toxicity that was seen in group II. Within one month of surgery, no significant difference was seen regarding grade =3 postoperative complications (p = 0.333). Conclusion: For patients with rectal cancer located at least 5 cm above the anal verge, short-course radiotherapy with concurrent and consolidation chemotherapy and delayed surgery is not different in terms of acute toxicity, postoperative morbidity, complete resection, and pathological response compared to long-course chemoradiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Seroprevalence of anti-Toxocara antibody among multiple sclerosis patients: a case–control study.
- Author
-
Khalili, Nastaran, Khalili, Neda, Nickhah, Ali, and Khalili, Bahman
- Abstract
Although previous studies have shown an association between parasitic infections and multiple sclerosis, the possible role of Toxocara infection on the etiology of multiple sclerosis has been overlooked. The present study aimed to investigate the seroprevalence of anti-Toxocara IgG antibodies among patients with multiple sclerosis compared to healthy controls. Seventy patients with prior diagnosis of multiple sclerosis were selected as cases and 70 healthy matched individuals as controls. The presence of serum anti-Toxocara IgG antibody was investigated by ELISA technique. The Chi square test was used to test statistically significant differences for parametric data. A total of 140 serum samples were collected and analyzed. In the case and control groups, 20 (28.6%) and 8 (11.4%) participants had positive serum anti-Toxocara IgG antibodies, respectively, indicating a statistically significant difference (OR 3.1; 95% CI 1.26–7.63; p value = 0.02). The seroprevalence rate was also higher among individuals with a history of contact with dogs (OR 2.7; 95% CI 1.17–6.37; p value = 0.03).The results declare that a protective role of Toxocara canis against the development of multiple sclerosis is unlikely. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Effects of lead and cadmium on the immune system and cancer progression.
- Author
-
Ebrahimi, Maryam, Khalili, Neda, Razi, Sepideh, Keshavarz-Fathi, Mahsa, Khalili, Nastaran, and Rezaei, Nima
- Subjects
IMMUNE system ,CADMIUM ,CANCER invasiveness ,HEAVY metals ,STREET food ,POLLUTANTS ,HUMAN body - Abstract
In our daily life, we are surrounded by harmful pollutants, including heavy metals that are not visible in the macroscopic view easily. Heavy metals can disrupt different aspects of human health, such as the immune system which has gained a lot of attention in recent decades. This had led to its rapid progression and new insights into its alterations in different diseases especially cancer. Heavy metals are non-biodegradable materials that exist in different parts of the food cycle, such as fruits and vegetables as commonly consumed foods and also unexpected sources such as street dust, that exists in the streets that we pass every day, soil, air, and water. These heavy metals can enter the human body through respiratory, cutaneous, and gastrointestinal pathways and then accumulate in different organs, leading to their encountering with various parts of the body. These sources and natural characteristics of heavy metals facilitate their interaction with the immune system. In this review, we investigated the effect of lead and cadmium, as pollutants that exist in many different parts of the human environment, on the immune system which is known to have a key role in the pathophysiology of cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers.
- Author
-
Gouravani, Mahdi, Khalili, Nastaran, Razi, Sepideh, Keshavarz-Fathi, Mahsa, Khalili, Neda, and Rezaei, Nima
- Subjects
CANCER ,INFLAMMASOMES ,CONTRAST effect ,BIOLOGY - Abstract
Introduction: Inflammasomes are large multimeric intracellular complexes that are capable of maturation and secretion of pro-inflammatory cytokines, IL-1β and IL-18, in response to danger signal molecules. As a member of the inflammasome family, the NLRP3 inflammasome has recently been under intense investigation revealing its possible role in several human diseases especially cancers. Areas covered: In this review, we will discuss the biology and mechanism of NLRP3 inflammasome activation, its role in specific types of tumors and the novel therapeutic modalities targeting this complex. Expert opinion: The NLRP3 inflammasome and its components including the adapter apoptosis-associated speck-like (ASC) protein and caspase-1 impose different and sometimes contrasting effects in tumorigenesis depending on various contexts. Considering the novel role of this complex in the initiation and progression of neoplasia, the NLRP3 inflammasome and its pathways provide desirable therapeutic targets for prevention, treatment, and prognosis of certain types of cancer. To date, several agents have been introduced for this purpose, some of which have shown promising results in the clinic. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Lobar Distribution of COVID-19 Pneumonia Based on Chest Computed Tomography Findings; A Retrospective Study.
- Author
-
Haseli, Sara, Khalili, Nastaran, Bakhshayeshkaram, Mehrdad, Taheri, Morteza Sanei, and Moharramzad, Yashar
- Published
- 2020
19. Specific immunotherapy in hepatocellular cancer: A systematic review.
- Author
-
Baradaran Noveiry, Behnoud, Hirbod‐Mobarakeh, Armin, Khalili, Nastaran, Hourshad, Niloufar, Greten, Tim F, Abou‐Alfa, Ghassan K, and Rezaei, Nima
- Subjects
IMMUNOTHERAPY ,LIVER cancer ,HEALTH outcome assessment ,CLINICAL immunology ,THERAPEUTICS - Abstract
Background and Aim In recent years, several novel immunotherapeutic approaches were developed and investigated in patients with hepatocellular carcinoma (HCC). We designed this systematic review, to evaluate clinical efficacy of specific immunotherapy in patients with HCC, according to the guidelines of Border of Immune Tolerance Education and Research Network (BITERN) and Cochrane collaboration. Methods We searched Medline, Scopus, CENTRAL, TRIP, DART, OpenGrey, and ProQuest through the 9th of December 2015. One author reviewed and retrieved citations from these seven databases for irrelevant and duplicate studies, and two other authors independently extracted data from the studies and rated their quality. We collated study findings and calculated a weighted treatment effect across studies using Review Manager. Results We found 12144 references in seven databases of which 21 controlled studies with 1885 HCC patients in different stages were included in this systematic review after the primary and secondary screenings. Overall, patients undergoing specific immunotherapy had significantly higher overall survival than those in control group (HR = 0.59; 95% CI = 0.47-0.76, P < 0.0001). There was a significant difference in recurrence-free survival between patients undergoing specific immunotherapy and patients in control groups and patients in immunotherapy groups overall had less recurrence than control group (HR = 0.54; 95% CI = 0.46-0.63, P < 0.00001). Conclusions Results of this systematic review based on the available literature suggest that overall specific immunotherapeutic approaches could be beneficiary for the treatment of patients with HCC. This further supports the current and ongoing evaluations of specific immunotherapies in the field. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
20. Specific immunotherapy in ovarian cancer: a systematic review.
- Author
-
Alipour, Soroush, Zoghi, Samaneh, Khalili, Nastaran, Hirbod-Mobarakeh, Armin, Emens, Leisha A, and Rezaei, Nima
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.